Greenwich LifeSciences, Inc. - 10-K Filing

Greenwich LifeSciences filed its annual report on Form 10-K for the fiscal year ended December 31, 2025. The filing includes financial data showing a common stock market value of approximately $9.07 per share as of June 30, 2025, with around 6 million shares held by non-affiliates valued at about $56 million.

SEC EDGAR · June 1, 2026, 20:56 UTC

Tickers: $GLSI

Read the full article at SEC EDGAR

More Regulatory news

Home Federal Bancorp, Inc. of Louisiana - 10-Q Filing SEC EDGAR · November 12, 2026, 17:12 UTC
LiveRamp Holdings, Inc. - 10-Q Filing SEC EDGAR · November 12, 2026, 16:52 UTC
Presurance Holdings, Inc. - 8-K Filing SEC EDGAR · November 12, 2026, 16:43 UTC
EXPEDITORS INTERNATIONAL OF WASHINGTON INC - 8-K Filing SEC EDGAR · November 12, 2026, 16:42 UTC
AUDIOEYE INC - 10-Q Filing SEC EDGAR · October 26, 2026, 21:11 UTC
ROCKWELL AUTOMATION, INC - 10-K Filing SEC EDGAR · November 12, 2026, 16:35 UTC
United KSK Corp - 10-Q Filing SEC EDGAR · November 12, 2026, 16:29 UTC
AMERICAN SHARED HOSPITAL SERVICES - 8-K Filing SEC EDGAR · November 12, 2026, 16:27 UTC
VIVIC CORP. - 10-K Filing SEC EDGAR · November 12, 2026, 16:26 UTC
WOLVERINE WORLD WIDE INC /DE/ - 10-Q Filing SEC EDGAR · November 12, 2026, 16:24 UTC